Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian B McDermott

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.
Medrxiv : the Preprint Server for Health Sciences|March 2, 2022
Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19Rachel Sparks, William W Lau, Can Liu, et al.
Nature|January 4, 2023
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19Rachel Sparks, William W Lau, Can Liu, et al.
The Journal of Experimental Medicine|October 8, 2008
Macaques vaccinated with live-attenuated SIV control replication of heterologous virusMatthew R Reynolds, Andrea M Weiler, Kim L Weisgrau, et al.
Vaccines|November 13, 2020
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive AntibodiesJuan Manuel Carreño, Jacqueline U McDonald, Tara Hurst, et al.
Nature Medicine|September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trialBoris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Science Translational Medicine|April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humansSarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, et al.
Science Translational Medicine|January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primatesMadhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Journal of Virology|July 8, 2011
Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimenNicola Winstone, Aaron J Wilson, Gavin Morrow, et al.
The Journal of Infectious Diseases|September 25, 2021
Stable Latent HIV Infection and Low-level Viremia Despite Treatment With the Broadly Neutralizing Antibody VRC07-523LS and the Latency Reversal Agent VorinostatCynthia L Gay, Katherine S James, Marina Tuyishime, et al.
Medrxiv : the Preprint Server for Health Sciences|March 2, 2022
Influenza vaccination and single cell multiomics reveal sex dimorphic immune imprints of prior mild COVID-19Rachel Sparks, William W Lau, Can Liu, et al.
Nature|January 4, 2023
Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19Rachel Sparks, William W Lau, Can Liu, et al.
The Journal of Experimental Medicine|October 8, 2008
Macaques vaccinated with live-attenuated SIV control replication of heterologous virusMatthew R Reynolds, Andrea M Weiler, Kim L Weisgrau, et al.
Vaccines|November 13, 2020
Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive AntibodiesJuan Manuel Carreño, Jacqueline U McDonald, Tara Hurst, et al.
Nature Medicine|September 12, 2024
Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1/2a trialBoris Julg, Victoria E K Walker-Sperling, Kshitij Wagh, et al.
STAR Protocols|September 21, 2023
Ultrasound-guided lymph node fine-needle aspiration for evaluating post-vaccination germinal center responses in humansLarissa L S Scholte, David J Leggat, Kristen W Cohen, et al.
Science Translational Medicine|April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humansSarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, et al.
Science Translational Medicine|January 3, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primatesMadhu Prabhakaran, Flavio Matassoli, David Leggat, et al.
Pageof 18